SpringerLink
Log in

The role of bone marrow morphology in the diagnosis of relapsed acute myeloid leukemia

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zhou Y, Wood BL, Walter RB, Becker PS, Percival M-E, Bar M et al. Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed? Leukemia 2017; e-pub ahead of print 18 August 2017doi:10.1038/leu.2017.263.

    Article  CAS  Google Scholar 

  2. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391–2405.

    Article  CAS  Google Scholar 

  3. Ivey A, Hills RK, Simpson MA, Jovanovic JV, Gilkes A, Grech A et al. Assessment of minimal residual disease in standard-risk AML. N Engl J Med 2016; 374: 422–433.

    Article  CAS  Google Scholar 

  4. Tobal K, Newton J, Macheta M, Chang J, Morgenstern G, Evans PA et al. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse. Blood 2000; 95: 815–819.

    CAS  PubMed  Google Scholar 

  5. Grimwade D, Jovanovic JV, Hills RK, Nugent EA, Patel Y, Flora R et al. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. J Clin Oncol 2009; 27: 3650–3658.

    Article  CAS  Google Scholar 

  6. Young AL, Challen GA, Birmann BM, Druley TE . Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun 2016; 7: 12484.

    Article  CAS  Google Scholar 

  7. Koeffler HP, Leong G . Preleukemia: one name, many meanings. Leukemia 2017; 31: 534–542.

    Article  CAS  Google Scholar 

  8. Uy GL, Duncavage EJ, Chang GS, Jacoby MA, Miller CA, Shao J et al. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy. Leukemia 2017; 31: 872–881.

    Article  CAS  Google Scholar 

  9. Hourigan CS, Gale RP, Gormley NJ, Ossenkoppele GJ, Walter RB . Measurable residual disease testing in acute myeloid leukaemia. Leukemia 2017; 31: 1482–1490.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

Author contributions

BS and AR developed the concept. BS, SG and AR wrote the manuscript. DW critically evaluated the manuscript.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA

    B Said, D Weisdorf & A Rashidi

  2. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA

    S Gilles

Authors
  1. B Said
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Gilles
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Weisdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Rashidi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Rashidi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Said, B., Gilles, S., Weisdorf, D. et al. The role of bone marrow morphology in the diagnosis of relapsed acute myeloid leukemia. Leukemia 32, 1052 (2018). https://doi.org/10.1038/leu.2017.308

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2017.308

  • Springer Nature Limited

Search

Navigation